keep in mind that if we convert the current share price into pre rights $$$ the current share price is already over $1.I recon it could go much higher based on future earnings, but the asset play is over.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025